References
- Palacios-Jaraquemada JM, Fiorillo A, Hamer J, et al. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med. 2022;35(2):275–7. doi: 10.1080/14767058.2020.1716715
- Takahashi H, Ohkuchi A, Usui R, et al. Matsubara-Takahashi cervix-holding technique for massive postpartum hemorrhage in patients with placenta previa with or without placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140(3):357–364. doi: 10.1002/ijgo.12390
- Sichitiu J, El-Tani Z, Mathevet P, et al. Conservative surgical Management of placenta accreta spectrum: a pragmatic approach. J Invest Surg. 2021;34(2):172–180. doi: 10.1080/08941939.2019.1623956
- Barinov SV, Shmakov RG, Medyannikova IV, et al. Efficacy of distal haemostasis during caesarean delivery in women with placenta accreta spectrum disorders. J Matern Fetal Neonatal Med. 2021;35:1–8. doi: 10.1080/14767058.2021.2005019
- Hu Q, Li C, Luo L, et al. Clinical analysis of second-trimester pregnancy termination after previous caesarean delivery in 51 patients with placenta previa and placenta accreta spectrum: a retrospective study. Bmc Pregnancy Childbirth. 2021;21(1):568. doi: 10.1186/s12884-021-04017-8
- Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20–24. doi: 10.1002/ijgo.12761
- Ekmekci E, Gencdal S. What’s happening when the pregnancies are not terminated in case of anencephalic fetuses? J Clin Med Res. 2019;11(5):332–336. doi: 10.14740/jocmr3777
- Hsiao CH, Chen CH, Chang YF, et al. Retrospective analysis of stillbirth and induced termination of pregnancies: factors affecting determination. Taiwan J Obstet Gynecol. 2022;61(4):626–629. doi: 10.1016/j.tjog.2022.05.002
- Ou J, Peng P, Teng L, et al. Management of patients with placenta accreta spectrum disorders who underwent pregnancy terminations in the second trimester: a retrospective study. Eur J Obstet Gynecol Reprod Biol. 2019;242:109–113. doi: 10.1016/j.ejogrb.2019.09.014
- Cui R, Li M, Lu J, et al. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study. Bmc Pregnancy Childbirth. 2018;18(1):298. doi: 10.1186/s12884-018-1935-6
- Huang J, Zhang X, Liu L, et al. Placenta accreta spectrum outcomes using tourniquet and forceps for vascular control. Front Med. 2021;8:557678. doi: 10.3389/fmed.2021.557678
- Yu F, Leung KY. Antenatal diagnosis of placenta accreta spectrum (PAS) disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:13–24. doi: 10.1016/j.bpobgyn.2020.06.010
- Bouariu A, Panaitescu AM, Nicolaides KH. First trimester prediction of adverse pregnancy outcomes-identifying pregnancies at risk from as Early as 11-13 weeks. Medicina. 2022;58(3):332. doi: 10.3390/medicina58030332
- Pekar-Zlotin M, Melcer Y, Maymon R, et al. Second-trimester levels of fetoplacental hormones among women with placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140(3):377–378. doi: 10.1002/ijgo.12352
- Stănculescu RV, Brătilă E, Socolov DG, et al. Update on placenta accreta spectrum disorders by considering epidemiological factors, ultrasound diagnosis and pathological exam - literature review and authors’ experience. Rom J Morphol Embryol. 2022;63(2):293–305. doi: 10.47162/RJME.63.2.02
- Kingdom JC, Hobson SR, Murji A, et al. Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020. Am J Obstet Gynecol. 2020;223(3):322–329. doi: 10.1016/j.ajog.2020.01.044
- Di Mascio D, Calì G, D’Antonio F. Updates on the management of placenta accreta spectrum. Minerva Ginecol. 2019;71(2):113–120. doi: 10.23736/S0026-4784.18.04333-2
- Sumigama S, Kotani T, Hayakawa H. Stepwise treatment for abnormally invasive placenta with placenta previa. Surg J (N Y). 2021;7(Suppl 1):S20–S27. doi: 10.1055/s-0041-1728748
- Capannolo G, D’Amico A, Alameddine S, et al. Placenta accreta spectrum disorders clinical practice guidelines: a systematic review. J Obstet Gynaecol Res. 2023;49(5):1313–1321. doi: 10.1111/jog.15544
- Bai GQ, Chen WL, Huang XH, et al. Evaluation of the diagnosis and treatment of cesarean scar pregnancy induced in the second trimester: a national multicenter retrospective study. Zhonghua Fu Chan Ke Za Zhi. 2021;56(8):545–553. doi: 10.3760/cma.j.cn112141-20210331-00167
- Ou J, Peng P, Teng L, et al. Reply to letter to the editor entitled ‘re: management of patients with placenta accreta spectrum disorders who underwent pregnancy terminations in the second trimester: a retrospective study’. Eur J Obstet Gynecol Reprod Biol. 2020;246:191. doi: 10.1016/j.ejogrb.2020.01.006
- Zhou T, Lu W, Wang W, et al. The efficacy and Postoperative follow-up of different interventional methods in cesarean section for placenta accreta spectrum disorders. Med Sci Monit. 2021;27:e932674. doi: 10.12659/MSM.932674
- Chen M, Liu X, You Y, et al. Internal iliac artery balloon occlusion for placenta previa and suspected placenta accreta: a randomized controlled trial. Obstet Gynecol. 2020;135(5):1112–1119. doi: 10.1097/AOG.0000000000003792
- Peng Y, Jiang L, Peng C, et al. The application of prophylactic balloon occlusion of the internal iliac artery for the treatment of placenta accreta spectrum with placenta previa: a retrospective case-control study. Bmc Pregnancy Childbirth. 2020;20(1):349. doi: 10.1186/s12884-020-03041-4
- Frank WM, Maymon S, Shnaider O, et al. Two approaches for placenta accreta spectrum: B-lynch suture versus pelvic artery endovascular balloon. J Matern Fetal Neonatal Med. 2020;33(16):2711–2717. doi: 10.1080/14767058.2018.1558199
- Choo S, Wiseman D, MacMillan JB, et al. Myometrial defect in a subsequent pregnancy after uterine artery embolization for postpartum hemorrhage, in the absence of leiomyomas or previous uterine surgery. J Obstet Gynaecol Can. 2020;42(2):173–176. doi: 10.1016/j.jogc.2019.04.013
- Takahashi H, Baba Y, Usui R, et al. Hemostatic effect of combined procedures for placenta previa: cervix-holding, intrauterine balloon, and uterine compression suture. J Matern Fetal Neonatal Med. 2021;35:1–7. doi: 10.1080/14767058.2021.1999922
- Smith CG, Cottrill HM, Barton JR. Reloadable stapler use during peripartum hysterectomy for placenta accreta spectrum: a novel surgical technique and case series. Am J Perinatol. 2022;39(3):265–271. doi: 10.1055/s-0040-1715464
- Zhu L, Lu J, Huang W, et al. A modified suture technique for the treatment of patients with pernicious placenta previa and placenta accreta spectrum: a case series. Ann Transl Med. 2021;9(14):1140. doi: 10.21037/atm-21-2318
- Elfeky A, Son MA, Paiva C, et al. Elective robotic hysterectomy for placenta accreta spectrum in the second trimester: case report. Int J Surg Case Rep. 2020;72:361–364. doi: 10.1016/j.ijscr.2020.06.024
- Jauniaux E, Silver RM. Rethinking prenatal screening for anomalies of placental and umbilical cord implantation. Obstet Gynecol. 2020;136(6):1211–1216. doi: 10.1097/AOG.0000000000004175
- Hecht JL, Baergen R, Ernst LM, et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020;33(12):2382–2396. doi: 10.1038/s41379-020-0569-1